A prominent medical advocacy group is urging the Federal Trade Commission to probe whether the American Psychological Association knowingly promoted transgender surgeries on minors while being aware of the pitfalls.
Do No Harm, a group aimed at “protecting healthcare from identity politics,” argued to FTC Chairman Andrew Ferguson that the association’s 2024 policy statement in support of such operations on minors contradicts its statement to regulators last September.
In 2024, the APA, which touts some 173,000 members, stressed the “necessity for access to comprehensive, gender-affirming healthcare for transgender, gender-diverse, and nonbinary children” and decried “misinformation” stigmatizing such interventions.
A little over a year later, the group struck a somewhat nuanced tone with FTC, emphasizing that a gender dysphoria “diagnosis does not automatically mean social or medical transition.”
“The contradictory messages – which expose the APA for telling federal regulators one thing, and gender activists another – raise concerns that the APA may be knowingly promoting so-called ‘gender-affirming care’ (GAC) for minors in violation of Section 5 of the Federal Trade Commission (FTC) Act,” Do No Harm wrote to Ferguson.
